Dominik Beer, DO
Cardiovascular Disease · Danville, PANPI 1407271281
Payments from drug & device makers
Across 200 payments — averaging $434.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$47K
- Biotronik Inc.$19K
- Medtronic$10K
- Boston Scientific$6K
- Altathera Pharmaceuticals LLC$2K
- Philips North America LLC$2K
- plus $731 from 2 others
What the payments were for
- Consulting fees$30,77035%
- Speaking & faculty fees$1,8002%
- Grants$14,63717%
- Travel & lodging$30,89336%
- Food & beverage$7,5779%
- Education$1,1251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 91 | $46,632 |
| Biotronik Inc. | 44 | $19,395 |
| Medtronic(2 entities) | 28 | $10,402 |
| Boston Scientific | 13 | $5,716 |
| Altathera Pharmaceuticals LLC | 3 | $2,259 |
| Philips North America LLC | 9 | $1,667 |
| AstraZeneca | 10 | $633 |
| Biosense Webster, Inc. | 2 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCENT$18,791
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$12,087
- AVEIR$5,160
- GENERAL BRADY$5,000
- TENDRIL$3,900
- Sotalol Hydrochloride$2,201
- ASSURITY$1,382
- (9124) LM Undivided$1,070
- HeartMate 3 Left Ventricular Dev$424
- Acticor 7 VR-T DX$365
- GENERAL - THERAPIES$348
- Selectra$299
- (9520) IGT Devices Undivided$293
- BioMonitor$267
- Micra$257
- ENSITE PRECISION$231
- EVERA MRI XT DR SURESCAN$209
- Quadra Assura CRT Defibrillator$189
- COBALT DR MRI SURESCAN$123
- Rivacor 7 DR-T$117
How this compares
$86,801 in reported general payments places this provider in the 90th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 132 | $170,425 |
| XareltoRivaroxaban | 24 | $25,245 |
| JardianceEmpagliflozin | 13 | $7,818 |
| Metoprolol Succinate | 173 | $3,987 |
| Flecainide Acetate | 69 | $3,864 |
| Dofetilide | 20 | $1,974 |
| Amiodarone Hcl | 86 | $1,401 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 33 | $1,154 |
| SotalolSotalol Hcl | 30 | $843 |
| Carvedilol | 13 | $214 |
| Atorvastatin Calcium | 14 | $212 |
| Losartan Potassium | 16 | $190 |
| Amlodipine Besylate | 15 | $181 |
| Furosemide | 17 | $165 |
| Metoprolol Tartrate | 11 | $136 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Danville
- Jess OrenDanville$609K
- William HaynosDanville$336K
- Parash PokharelDanville$223K
- Shikhar AgarwalDanville$219K
- Danielle DuffyPhiladelphia$29.5M
- Venkatesh NadarCamp Hill$18.3M
- Hemal GadaWormleysburg$6.7M
- Brian DrachmanPhiladelphia$3.8M
- William BachinskyMechanicsburg$2.3M
- Bonnie KyPhiladelphia$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.